测试版
试验雷达 AI
临床试验 NCT05238103 (mTECH-Rehab) 针对冠状动脉疾病，心肌梗死，心肌缺血，冠状动脉闭塞，Coronary Artery Stenosis Stent，旁路移植闭塞，心脏瓣膜病目前已完成。请查看临床试验雷达卡片视图和 AI 发现工具了解所有详情，或在此提出任何问题。
一个试验符合筛选条件
卡片视图
返回搜索

Impact of a Corrie Cardiac Rehabilitation Program (mTECH-Rehab)

已完成
临床试验详情主要以英语提供。然而，试验雷达 AI可以提供帮助！只需点击“解释临床试验”即可查看和讨论您选择的语言的试验信息。
临床试验NCT05238103 (mTECH-Rehab)是一项针对冠状动脉疾病，心肌梗死，心肌缺血，冠状动脉闭塞，Coronary Artery Stenosis Stent，旁路移植闭塞，心脏瓣膜病的干预性研究试验，试验状态为已完成。试验开始于2023年4月3日，共计划招募259名患者。该研究由约翰·霍普金斯大学主导，已于2024年10月14日完成。试验数据来源于ClinicalTrials.gov，最后更新时间为2025年12月5日。
简要概括
In this randomized clinical trial, the researchers are investigating whether a multi-component virtual/hybrid cardiac rehabilitation program will improve functional status, cholesterol level, overall cardiovascular health, individual risk factors, quality of life and mental health for patients who have recently been diagnosed with myocardial infarction, received a coronary stent, underwent heart surgery or catheter-based valve replacement, as compared to traditional, center-based cardiac rehabilitation.
官方标题

Impact of a Mobile Technology Enabled Corrie Cardiac Rehabilitation Program on Functional Status and Cardiovascular Outcomes (mTECH-Rehab): A Randomized Controlled Trial

疾病
冠状动脉疾病心肌梗死心肌缺血冠状动脉闭塞Coronary Artery Stenosis Stent旁路移植闭塞心脏瓣膜病
出版物
关于此临床试验发表的科学文章和研究论文：
其他研究标识符
  • mTECH-Rehab
  • IRB00308410
NCT编号
NCT05238103
实际开始日期
2023-04-03
最近更新发布
2025-12-05
预计完成日期
2024-10-14
计划入组人数
259
研究类型
干预性研究
试验分期 (阶段)
不适用
试验状态
已完成
关键词
digital health
smartphone app
self-management
guideline adherence
behavior modification
community engagement
主要目的
支持治疗
分配方式
随机
干预模型
平行
盲法
单盲
试验组/干预措施
参与者组/试验组干预措施/治疗方法
实验性Corrie Hybrid Cardiac Rehabilitation Program (Intervention Group)
Receives Corrie Virtual Cardiac Rehabilitation Program along with option to continue traditional, center-based cardiac rehabilitation.
Corrie Hybrid Cardiac Rehabilitation Program
The Corrie Hybrid Cardiac Rehabilitation Program is a multi-component intervention. It consists of the Corrie smartphone app for cardiovascular health optimization which is paired with wristband device (Apple Watch or Fitbit), Bluetooth-enabled Omron blood pressure monitor and exercise resistance bands. The program also includes individualized treatment plan development, setting health goals and communication with trained Corrie Health Coach. Furthermore, the intervention includes motivational text messages sent to participants throughout the study to aid with risk factor modification.
无干预Facilitated Center-Based Cardiac Rehabilitation Program (Control Group)
Receives traditional, center-based cardiac rehabilitation. The study team will help facilitate the logistics of receiving center-based cardiac rehabilitation, including proper referrals.
不适用
主要终点
结果指标度量标准描述时间框架
6-minute Walking Distance (Meters)
Mean difference in 6 minute walk distance, between Intervention and Control groups, as measured at final study visit occurring at 12 weeks after randomization.
12 weeks after randomization
次要终点
结果指标度量标准描述时间框架
Composite Cardiovascular Health Metric for Secondary Prevention
The cardiovascular health metric for secondary prevention (adapted from American Heart Association's Life Simple 7). The score ranges from 0 to 14 with higher score indicating better cardiovascular health.
12 weeks after randomization
Blood Pressure (mmHg)
Systolic blood pressure and Diastolic blood pressure
12 weeks after randomization
Low Density Lipoprotein - Cholesterol (LDL-C)
LDL cholesterol level (in mg/dl) measured through blood sample drawn at 12 week follow up visit
12 weeks after randomization
Glycosylated Hemoglobin (HbA1c)
Glycosylated hemoglobin (HbA1c) level (%) measured through blood sample drawn at 12 week follow up visit
12 weeks after randomization
Body Mass Index (kg/m^2)
BMI = weight (kg) / height in meters squared (m\^2). Weight and height measured by study staff at study visit.
12 weeks after randomization
Quality of Life as Assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health-10
Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health-10: The 10-item patient-reported questionnaire administered at 12 weeks follow up in which the response options are presented as 5-point (as well as a single 11-point) rating scales. The results of the questions are used to calculate two summary scores: a Global Physical Health Score and a Global Mental Health score. These scores are then standardized to the general population, using the "T-Score". The average "T-Score" for the United States population is 50 points, with a standard deviation of 10 points. Higher scores indicate a healthier patient.
12 weeks after randomization
Blood Pressure Control
Blood pressure control (Cardiovascular secondary health metric component). Ideal (SBP \<130 mmHg and DBP \<90 mmHg). Intermediate (SBP 130-139 mmHg or DBP 80-89 mmHg). Poor (SBP ≥140 mmHg or DBP ≥90 mmHg).
12 weeks after randomization
Cholesterol (LDL-C) Control
Cholesterol (LDL-C) control (Cardiovascular secondary health metric component). Ideal (LDL-C \<70mg/dL). Intermediate (LDL-C 70-99 mg/dL). Poor (LDL-C ≥100mg/dL)
12 weeks after randomization
Diabetes Control
Diabetes (HbA1c) control (Cardiovascular secondary health metric component). Ideal (HbA1c \<7% for diabetic, \<5.7% for non-diabetic). Intermediate (HbA1c 7.0-7.9% for diabetic, 5.0-5.9% for non-diabetic). Poor (HbA1c ≥8% for diabetic, ≥6.5% for non-diabetic).
12 weeks after randomization
Weight (BMI) Categories
Weight (BMI) categories (Cardiovascular secondary health metric component). Ideal (BMI \<25 kg/m\^2). Intermediate (BMI 25-29 kg/m\^2). Poor (BMI ≥ 30 kg/m\^2).
12 weeks after randomization
Physical Activity Categories
Physical activity categories (Cardiovascular secondary health metric component). Ideal (≥150 min/wk moderate physical activity, ≥75 min/wk vigorous physical activity). Intermediate (1-149 min/wk moderate physical activity, 1-74 min/wk vigorous physical activity). Poor (No regular exercise).
12 weeks after randomization
Diet Categories
Diet categories (Cardiovascular secondary health metric component). Ideal (Rate Your Plate score 64-81). Intermediate (Rate Your Plate score 46-63). Poor (Rate Your Plate score 27-45).
12 weeks after randomization
Tobacco Use
Tobacco use categories (Cardiovascular secondary health metric component). Ideal (never). Intermediate (Former smoker). Poor (Recent/Current smoker).
12 weeks after randomization
Cardiac Rehabilitation Engagement
Cardiac rehabilitation engagement as measured by number of participants who attended the sessions per category. Grouped by Healthcare Effectiveness Data and Information Set (HEDIS) categories: Initiation (0-12 sessions attended), Engagement 1 (13-24 sessions attended), Engagement 2 (25-36 sessions attended).
12 weeks after randomization
资格标准

适龄参与研究
成人, 老年人
最低年龄要求
18 Years
适龄性别
全部
  • 18 years or older
  • Individuals admitted to the hospital for the following conditions or interventions during the index admission: Acute myocardial infarction (STEMI or NSTEMI type 1), Coronary artery bypass grafting (CABG), and Coronary artery angioplasty/stenting (PCI), Heart valve surgery, catheter-based aortic valve replacement (TAVR).

  • Non-English speaking

  • Symptomatic severe aortic stenosis or other severe valvular disease

  • Physical disability that would preclude safe and adequate exercise performance

  • Hypertrophic obstructive cardiomyopathy with peak resting left ventricular outflow gradient of >25 mmHg

  • Known aortic dissection

  • Severe resting arterial hypertension (Systolic blood pressure >200 mmHg or diastolic BP >110mmHg) at baseline assessment

  • Mental impairment leading to inability to cooperate with study procedures

  • Untreated high degree atrioventricular block

  • Atrial fibrillation with uncontrolled ventricular rate (Heart rate >110 at rest) at baseline assessment

  • History of cardiac arrest or sudden death

  • Myocardial infarction or cardiac surgery complications with cardiogenic shock and/or congestive heart failure and/or signs/symptoms of post-procedure ischemia

  • Left ventricular ejection fraction <40%

  • History of Clinically significant depression

  • Visual or hearing impairment which precludes the use of the intervention

  • Presence of cardiac defibrillator

  • Incomplete revascularization procedure

  • History of one or more episodes of falls in the last year

  • Pregnancy

    • If patients are deemed clinically unstable and unable to participate at the time of initial screening, the research team member may return at a later date to determine whether this status has changed.
Johns Hopkins University logo约翰·霍普金斯大学587 个活跃的临床试验可供探索
  • American Heart Association logoAmerican Heart Association
  • Apple Inc. logoApple Inc.
没有联系数据。
1 位于 1 个国家/地区的研究中心

Maryland

Johns Hopkins University, Baltimore, Maryland, 21287, United States